Alfred Sandrock, President and CEO at Voyager Therapeutics, Inc. (VYGR), sold 11,702 shares at $4.24 ($50K) on 2025-02-20, disclosed to the SEC on 2025-02-24.
Open-market sale of $50k VYGR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |